Cystic Fibrosis News Today Weekly Digest

Cystic Fibrosis Weekly Update Contents: Synspira’s Candidate SNSP113 Wins FDA Orphan Designation to Treat Bacterial Infections in Cystic Fibrosis Let’s Talk About What a CF Cure Really Means Synspira’s Candidate SNSP113 Wins FDA Orphan Designation to Treat Bacterial Infections in Cystic Fibrosis Oct 15, 2018 10:30 am | Patricia Inacio, PhD Synspira’s inhaled SNSP113 candidate therapy against bacterial biofilms in the lungs of patients with cystic fibrosis (CF) has received orphan drug status by the U.S. Food and Drug Administration (FDA). The buildup of mucus in CF patients’ organs, including the lungs, promotes the development of bacterial biofilms — aggregates of bacteria that adhere to the lungs’ surface. Biofilms make it harder […] The post Synspira’s Candidate SNSP113 Wins FDA Orphan Designation to Treat Bacterial Infections in Cystic Fibrosis appeared first on Cystic Fibrosis News Today. Read More Let’s Talk About What a CF Cure Really Means Oct 15, 2018 09:00 am | Tré LaRosa If you read my column last week, you know I care a lot about the interpretation of words. The word “cure” holds tremendous gravity in the cystic fibrosis community and for scientists. It’s the Holy Grail of CF science and what we ultimately work toward. CF is a progressive disease, meaning that our bodies become […] The post Let’s Talk About What a CF Cure Really Means appeared first on Cystic Fibrosis News Today. Read More   Recent News Synthetic Antimicrobial Peptide Can Destroy Biofilms in CF Patients, Study Reports Why It’s Better to Be Open About CF, Especially When Dating Bicarbonate Eyed as Weapon to Combat 2 Most Prevalent Bacteria in CF What You Need to Know About Romance, or the Lack of, When You Have CF Advocacy Groups, Doctors Question Rising Prices of Rare Disease Treatments